Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy

CK Osborne, R Schiff, G Arpino, AS Lee… - The Breast, 2005 - Elsevier
The receptor for the female hormone progesterone (PR), like that for estrogen (ER), is an
important predictive marker for response to endocrine therapy in patients with breast cancer …

[引用][C] Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.

C Kent Osborne, R Schiff, G Arpino, AS Lee… - THE BREAST, 2005 - iris.unina.it
Endocrine responsiveness: understanding how progesterone receptor can be used to select
endocrine therapy. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste …

Endocrine responsiveness: Understanding how progesterone receptor can be used to select endocrine therapy

CK Osborne, R Schiff, G Arpino, AS Lee… - The Breast, 2005 - infona.pl
The receptor for the female hormone progesterone (PR), like that for estrogen (ER), is an
important predictive marker for response to endocrine therapy in patients with breast cancer …

Endocrine responsiveness: Understanding how progesterone receptor can be used to select endocrine therapy

CK Osborne, R Schiff, G Arpino, AS Lee… - The …, 2005 - thebreastonline.com
The receptor for the female hormone progesterone (PR), like that for estrogen (ER), is an
important predictive marker for response to endocrine therapy in patients with breast cancer …

Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy

CK Osborne, R Schiff, G Arpino… - Breast (Edinburgh …, 2005 - pubmed.ncbi.nlm.nih.gov
The receptor for the female hormone progesterone (PR), like that for estrogen (ER), is an
important predictive marker for response to endocrine therapy in patients with breast cancer …

Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy.

CK Osborne, R Schiff, G Arpino, AS Lee… - Breast (Edinburgh …, 2005 - europepmc.org
The receptor for the female hormone progesterone (PR), like that for estrogen (ER), is an
important predictive marker for response to endocrine therapy in patients with breast cancer …